Experiment 970976

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVO

Compounds isolated

BRYONOLIC ACID

Details

PropertyValue
Pharmacology
DELAYED TYPE CUTANEOUS HYPERSENSITIVITY INHIBITION
Administration routeIP
OrganismLuffa aegyptiaca (CUCURBITACEAE)
CitationTANAKA,S: UNO,C: AKIMOTO,M: TABATA,M: HONDA,C: KAMISAKO,W:. (1991). ANTI-ALLERGIC EFFECT OF BRYONOLIC ACID FROM LUFFA CYLINDRICA CELL SUSPENSION CULTURES.. 57(6)
Amount utilized
Compound isolated
DiseaseVS.PICRYL CHLORIDE-INDUCED CONTACT HYPERSENSITIVITY.
Dose amount100.0 MG
Number5
Qualitative resultACTIVE
AnimalMOUSE
Per unitKG
Dose expressionDOSE